These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. Goodwin GM J Clin Psychiatry; 1996; 57 Suppl 4():9-13. PubMed ID: 8636065 [TBL] [Abstract][Full Text] [Related]
9. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]. Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113 [TBL] [Abstract][Full Text] [Related]
10. The safety and tolerability of citalopram. Muldoon C Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():35-40. PubMed ID: 8732443 [TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776 [TBL] [Abstract][Full Text] [Related]
12. Citalopram in the treatment of depression and other potential uses in psychiatry. Tan JY; Levin GM Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of the pharmacology of serotonin reuptake inhibitors. Warrington SJ Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174 [TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Mandrioli R; Mercolini L; Saracino MA; Raggi MA Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078 [TBL] [Abstract][Full Text] [Related]
16. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Puech A; Montgomery SA; Prost JF; Solles A; Briley M Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045 [TBL] [Abstract][Full Text] [Related]
17. Development of new antidepressants. Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Kyle CJ; Petersen HE; Overø KF Depress Anxiety; 1998; 8(4):147-53. PubMed ID: 9871816 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
20. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Preskorn SH Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]